cancer vaccine news from FiercePharma
NewsIt's Merck v. Glaxo in vaccine battle
Call it the battle of the HPV vaccines. For the past week, either Merck's Gardasil or GlaxoSmithKline's Cervarix--or both--have captured headlines: • Glaxo submits Cervarix for approval in Japan... Read more...
| Press ReleasesMulti-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma PatientsMulti-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients PARIS, and TORONTO, Sept 17, 2008 -- PARIS, and TORONTO, Sept. 17 /PRNewswire/ -- Sanofi pasteur, the vaccines Read more >> |
Get more cancer vaccine coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
